Age-Related Therapeutics
Part of Longevity & Aging
 MDT | Medtronic plc | $119.2b | $86.91 | -0.1% | 29.9M |
 EW | Edwards Lifesciences Corp | $52.3b | $85.55 | -0.0% | 1.7M |
 ALC | Alcon Inc. Ordinary Shares | $34.9b | $63.75 | -0.3% | 1.1M |
 BIIB | Biogen Inc. Common Stock | $32.9b | $223.10 | -1.3% | 578.5K |
 ZBH | Zimmer Biomet Holdings, Inc. | $18.9b | $88.28 | +0.3% | 1.5M |
 GKOS | Glaukos Corporation | $10.6b | $163.75 | +0.4% | 582.0K |
 BLCO | Bausch + Lomb Corporation | $6.4b | $17.76 | +1.0% | 295.2K |
 DNLI | Denali Therapeutics Inc. Common Stock | $3.7b | $20.33 | -2.5% | 1.3M |
 BVS | Bioventus Inc. Class A Common Stock | $1.0b | $13.14 | -2.3% | 289.6K |
 AVR | Anteris Technologies Global Corp. Common Stock | $0.8b | $7.71 | +1.3% | 878.2K |
 BIOA | BioAge Labs, Inc. Common Stock | $446.6m | $6.70 | -2.8% | 689.6K |
 ALEC | Alector, Inc. Common Stock | $303.7m | $1.82 | -2.4% | 865.4K |
 ACIU | AC Immune SA | $282.4m | $2.73 | -2.8% | 304.5K |
 ABOS | Acumen Pharmaceuticals, Inc. Common Stock | $224.2m | $2.04 | -1.4% | 547.6K |
 ACOG | Alpha Cognition Inc. Common Stock | $202.9m | $9.24 | +6.0% | 189.9K |
 LENZ | LENZ Therapeutics, Inc. Common Stock | $182.2m | $3.67 | -5.4% | 1.0M |
 OTLK | Outlook Therapeutics, Inc. Common Stock | $157.5m | $0.60 | +3.0% | 5.5M |
 CGTX | Cognition Therapeutics, Inc. Common Stock | $99.8m | $0.94 | +3.8% | 290.4K |
 TELO | Telomir Pharmaceuticals, Inc. Common Stock | $79.8m | $1.26 | +0.4% | 58.0K |
 ANVS | Annovis Bio, Inc. | $72.4m | $1.15 | +0.9% | 639.5K |
 COCH | Envoy Medical, Inc. Class A Common Stock | $53.3m | $0.68 | +3.0% | 160.3K |
 CRVO | CervoMed Inc. Common Stock | $39.9m | $3.13 | +2.7% | 209.2K |
 LGVN | Longeveron Inc. Common Stock | $21.6m | $2.56 | -1.9% | 18.8K |
 OSRH | OSR Health, Inc. Common Stock | $15.7m | $0.11 | 0.0% | N/A |
 GRML | Greenland Mines Ltd. Common Stock | $15.5m | $7.84 | -13.9% | 4.0M |
 NRSN | NeuroSense Therapeutics Ltd. Ordinary Shares | $15.2m | $3.90 | -1.6% | 15.8K |
 FBLG | FibroBiologics, Inc. Common Stock | $13.0m | $1.17 | +1.2% | 146.3K |
 ALZN | Alzamend Neuro, Inc. Common Stock | $8.2m | $1.36 | +4.9% | 235.8K |
 AIDX | 20/20 Biolabs, Inc. Common Stock | $8.1m | $0.40 | +2.4% | 63.3K |
 HCWB | HCW Biologics Inc. Common Stock | $6.2m | $1.67 | -0.6% | 60.3K |